Moser P - Search Results

1

Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.

Castagné V, Porsolt RD, Moser P. Castagné V, et al. Among authors: moser p. Eur J Pharmacol. 2009 Aug 15;616(1-3):128-33. doi: 10.1016/j.ejphar.2009.06.018. Epub 2009 Jun 21. Eur J Pharmacol. 2009. PMID: 19549518

2

Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.

Scheller D, Dürmüller N, Moser P, Porsolt RD. Scheller D, et al. Among authors: moser p. Eur J Pharmacol. 2008 Apr 14;584(1):111-7. doi: 10.1016/j.ejphar.2008.01.038. Epub 2008 Feb 5. Eur J Pharmacol. 2008. PMID: 18304531

3

Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.

Castagné V, Moser P, Roux S, Porsolt RD. Castagné V, et al. Among authors: moser p. Curr Protoc Pharmacol. 2010 Jun;Chapter 5:Unit 5.8. doi: 10.1002/0471141755.ph0508s49. Curr Protoc Pharmacol. 2010. PMID: 22294373

4

Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.

Castagné V, Moser P, Roux S, Porsolt RD. Castagné V, et al. Among authors: moser p. Curr Protoc Neurosci. 2011 Apr;Chapter 8:Unit 8.10A. doi: 10.1002/0471142301.ns0810as55. Curr Protoc Neurosci. 2011. PMID: 21462162

5

Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxide.

Froger-Colléaux C, Rompion S, Guillaume P, Porsolt RD, Castagné V, Moser P. Froger-Colléaux C, et al. Among authors: moser p. J Pharmacol Toxicol Methods. 2011 Jul-Aug;64(1):81-8. doi: 10.1016/j.vascn.2011.03.001. Epub 2011 Mar 23. J Pharmacol Toxicol Methods. 2011. PMID: 21406242

6

How good are current approaches to nonclinical evaluation of abuse and dependence?

Moser P, Wolinsky T, Duxon M, Porsolt RD. Moser P, et al. J Pharmacol Exp Ther. 2011 Mar;336(3):588-95. doi: 10.1124/jpet.110.169979. Epub 2010 Nov 22. J Pharmacol Exp Ther. 2011. PMID: 21098089 Review.

7

Current approaches and issues in non-clinical evaluation of abuse and dependence.

Moser P, Wolinsky T, Castagné V, Duxon M. Moser P, et al. J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):160-7. doi: 10.1016/j.vascn.2010.09.004. Epub 2010 Sep 22. J Pharmacol Toxicol Methods. 2011. PMID: 20868759

8

Preclinical behavioral models for predicting antipsychotic activity.

Castagné V, Moser PC, Porsolt RD. Castagné V, et al. Adv Pharmacol. 2009;57:381-418. doi: 10.1016/S1054-3589(08)57010-4. Epub 2009 Nov 27. Adv Pharmacol. 2009. PMID: 20230767 Review.

9

Behavioral indices in antipsychotic drug discovery.

Porsolt RD, Moser PC, Castagné V. Porsolt RD, et al. J Pharmacol Exp Ther. 2010 Jun;333(3):632-8. doi: 10.1124/jpet.110.166710. Epub 2010 Mar 3. J Pharmacol Exp Ther. 2010. PMID: 20200119

10

Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat.

Bourson A, Moser PC, Gower AJ, Mir AK. Bourson A, et al. Among authors: moser pc. Eur J Pharmacol. 1989 Feb 7;160(3):339-47. doi: 10.1016/0014-2999(89)90089-7. Eur J Pharmacol. 1989. PMID: 2469593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results